ASHPOfficial

Joel Hennenfent, Pharm.D., M.B.A., BCPS, FASHP, sits down with Ali McBride, Pharm.D., M.S., BCPS, to discuss biosimilar formulary implementation/integration and reimbursement challenges.

To learn more about Formulary Management Strategies visit www.formularytoolkit.org

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

At the intersection of two substantial public health challenges, practitioners are faced with reducing suffering from pain while also minimizing harm associated with high-risk analgesics.  Dr. Michele Matthews reviews the role of buprenorphine in acute and chronic pain management, the pharmacodynamics of buprenorphine, and clinical pearls for its use in practice.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Droperidol has come back to the market after several years of being unavailable. Today's episode will discuss its potential place in practice, along with practical considerations, such as dosing and monitoring. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Healthcare has been required to update the interface standard for e-prescribing by CMS on 1/1/2020, but what does it actually mean or change? The purpose of this podcast is to answer that question.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode is a recording of the Mindfulness and Meditation for Pharmacists and Pharmacy Technicians webinar from ASHP eLearning (no CE for podcast)

Activity Date: 10/2/2019

ASHP has been committed to supporting the well-being and resilience of the pharmacy workforce for decades. We have been even more focused on supporting members the last few years given recent evidence and impact of burnout on patient safety and the healthcare workforce. During COVID-19, demands and stress on the pharmacy workforce have increased to an even greater extent. Prior to the upcoming virtual Midyear Clinical Meeting, we offer you an opportunity to pause & participate in a guided heart rhythm meditation led by ASHP member, Lisa Wilhelm.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Midyear Clinical Meeting has gone virtual! Are you a student or resident preparing for the virtual showcase or PPS? Find out tips and tricks for navigating the virtual showcase, PPS, and virtual poster presentations. The podcast will feature a sneak-peek into ASHP's recent webinar ASHP Midyear Clinical Meeting Goes Virtual - Tips and Tricks for Navigating the Virtual Showcases.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In today's episode, we provide members with a breakdown of what the election results mean for pharmacy practice.  We discuss key Congressional committees, agency leadership, and what it all means for ASHP advocacy priorities. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Today's episode explores considerations worth taking into account when deciding to implement a medical surveillance program as recommended by the USP Chapter Standard.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

White bagging is a major patient safety issue driven by payers within hospitals today.  Candy Tsourounis, Pharm.D., FCSHP sits down with Joel Hennenfent, Pharm.D., MBA, BCPS, FASHP to discuss those safety issues and best practices on how to prevent white bagging to keep our patients safe.

To learn more about Formulary Management Strategies visit www.formularytoolkit.org.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join members of the ASHP New Practitioners Forum Resident Advancement Advisory Group as they share tips and tricks for Midyear participants to enhance their virtual experience. These ASHP volunteer leaders offer advice on how to prepare for the virtual Midyear Meeting, along with do and don’ts for virtual experiences and interviews.

Other resources to promote on web posting:

• Tips for a Successful Virtual Interview / MCM Checklist

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.